On the other hand, higher phosphorylated tau protein in CSF was associated with cSS and more severe imaging burden of CAA after exclusion of patients with Alzheimer's disease, which suggests a complex interplay between amyloid deposition, vascular damage, and neurodegeneration. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.